ATE361743T1 - Beschichtete minitabletten von venlafaxinhydrochlorid mit verlängerter freisetzung - Google Patents

Beschichtete minitabletten von venlafaxinhydrochlorid mit verlängerter freisetzung

Info

Publication number: ATE361743T1
Authority: AT; Austria
Prior art keywords: extended; venlafaxine hydrochloride; release coated; mini tablets; coated mini
Prior art date: 2004-02-04

Application number

AT04821278T

Other languages

English (en)

Inventor

Sampad Bhattacharya

Rajesh Kshirsagar

Mayank Joshi

Sandeep Pandita

Original Assignee

Alembic Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-02-04

Filing date

2004-10-27

Publication date

2007-06-15

2004-10-27 Application filed by Alembic Ltd filed Critical Alembic Ltd

2007-06-15 Application granted granted Critical

2007-06-15 Publication of ATE361743T1 publication Critical patent/ATE361743T1/de

Links

238000013265 extended release Methods 0.000 title abstract 3
239000008185 minitablet Substances 0.000 title abstract 2
229960002416 venlafaxine hydrochloride Drugs 0.000 title abstract 2
QYRYFNHXARDNFZ-UHFFFAOYSA-N venlafaxine hydrochloride Chemical compound [H+].[Cl-].C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 QYRYFNHXARDNFZ-UHFFFAOYSA-N 0.000 title abstract 2
239000007903 gelatin capsule Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Emergency Medicine (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AT04821278T 2004-02-04 2004-10-27 Beschichtete minitabletten von venlafaxinhydrochlorid mit verlängerter freisetzung ATE361743T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IN117MU2004		2004-02-04
IN980MU2004		2004-09-13

Publications (1)

Publication Number	Publication Date
ATE361743T1 true ATE361743T1 (de)	2007-06-15

Family

ID=34809925

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04821278T ATE361743T1 (de)	2004-02-04	2004-10-27	Beschichtete minitabletten von venlafaxinhydrochlorid mit verlängerter freisetzung

Country Status (23)

Country	Link
US (1)	US7807195B2 (de)
EP (1)	EP1711169B1 (de)
JP (1)	JP2007520547A (de)
KR (1)	KR20070000439A (de)
AT (1)	ATE361743T1 (de)
AU (1)	AU2004315136B2 (de)
BR (1)	BRPI0418283A (de)
CA (1)	CA2555295C (de)
CY (1)	CY1106741T1 (de)
DE (1)	DE602004006443T2 (de)
DK (1)	DK1711169T3 (de)
ES (1)	ES2287813T3 (de)
HR (1)	HRP20070353T3 (de)
IL (1)	IL177243A0 (de)
MX (1)	MXPA06008854A (de)
NO (1)	NO20063809L (de)
NZ (1)	NZ548504A (de)
PL (1)	PL1711169T3 (de)
PT (1)	PT1711169E (de)
RU (1)	RU2340331C2 (de)
SI (1)	SI1711169T1 (de)
UA (1)	UA82597C2 (de)
WO (1)	WO2005074895A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL146462A (en)	2001-11-13	2015-02-26	Lycored Bio Ltd	Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
AU2003278549A1 (en) *	2002-11-28	2004-06-18	Themis Laboratories Private Limited	Process for manufacturing sustained release microbeads containing venlafaxine hci
WO2006136927A1 (en) *	2005-06-22	2006-12-28	Glenmark Pharmaceuticals Limited	Extended release formulations comprising venlafaxine
WO2007016315A2 (en) *	2005-07-28	2007-02-08	Dr. Reddy's Laboratories Ltd.	Extended release venlafaxine compositions
WO2007102169A1 (en) *	2006-03-08	2007-09-13	Jubilant Organosys Limited	Extended release pharmaceutical formulation of venlafaxine and method of manufacturing the same
WO2007112574A1 (en) *	2006-04-03	2007-10-11	Isa Odidi	Extended release composition of venlafaxine
EP2010162A4 (de) *	2006-04-03	2013-01-09	Isa Odidi	Zusammensetzung zur abgabe eines arzneimittels
WO2007129329A2 (en) *	2006-05-08	2007-11-15	Jubilant Organosys Limited	Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
US20100120723A1 (en) *	2006-12-20	2010-05-13	Mostafa Akbarieh	Pharmaceutical composition comprising a hot-melt granulated lubricant
EP2124963A4 (de) *	2006-12-20	2010-03-17	Mylan Pharmaceuticals Ulc	Zusammensetzung mit einer bisphosphonsäure in kombination mit vitamin d
TWI391150B (zh) *	2008-01-22	2013-04-01	Taiwan Biotech Co Ltd	腸溶性長效塗覆芯與藥物劑型及其製造方法
CN101756934A (zh) *	2008-12-10	2010-06-30	上海复星普适医药科技有限公司	文拉法辛缓释制剂的制备方法
KR101787481B1 (ko)	2010-10-21	2017-10-18	롯데정밀화학 주식회사	장용성 경질 캡슐용 조성물 및 상기 조성물을 사용하여 제조된 장용성 경질 캡슐
US9789093B2 (en)	2011-01-31	2017-10-17	Serotech, Llc	Dosage regimen, medication dispensing package and uses thereof for the treatment of major depressive disorder
CN108366989B (zh)	2015-12-25	2020-11-03	富士胶片富山化学株式会社	含有1-(3-(2-(1-苯并噻吩-5-基-)乙氧基)丙基)氮杂环丁-3-醇或其盐的片剂
KR102062052B1 (ko) *	2018-03-20	2020-01-03	일양약품주식회사	베타네콜 서방성 제제 및 이의 제조방법
KR20230067863A (ko)	2021-11-10	2023-05-17	박찬호	스마트 계량도구 및 이를 이용한 요리보조 시스템

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4153677A (en) *	1978-05-18	1979-05-08	Sterling Drug Inc.	Controlled-release composition
US4535186A (en) *	1983-04-19	1985-08-13	American Home Products Corporation	2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US6440457B1 (en)	1993-05-27	2002-08-27	Alza Corporation	Method of administering antidepressant dosage form
US6274171B1 (en) *	1996-03-25	2001-08-14	American Home Products Corporation	Extended release formulation of venlafaxine hydrochloride
PE57198A1 (es)	1996-03-25	1998-10-10	American Home Prod	Formula de liberacion prolongada
UA77145C2 (en) *	1997-11-05	2006-11-15	Wyeth Corp	Extended release dosage formulation
IL139298A0 (en) *	1998-05-15	2001-11-25	Warner Lambert Co	Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
WO2001037815A1 (en)	1999-11-22	2001-05-31	Alza Corporation	Osmotic dosage form comprising first and second
US6346269B1 (en) *	2000-05-08	2002-02-12	Standard Chem. & Pharm. Co., Ltd.	Method for preparing an oral formulation containing acid-sensitive drugs and oral formulation made thereby
US6350471B1 (en) *	2000-05-31	2002-02-26	Pharma Pass Llc	Tablet comprising a delayed release coating
WO2002085335A1 (en) *	2001-04-18	2002-10-31	Nostrum Pharmaceuticals Inc.	A novel coating for a sustained release pharmaceutical composition
US20030091634A1 (en) *	2001-09-14	2003-05-15	Pawan Seth	Delayed release tablet of venlafaxin
JP2005516020A (ja)	2001-12-20	2005-06-02	ファルマシア・コーポレーション	ゼロ次持続放出剤形およびその製造方法
AU2002217373A1 (en) *	2002-01-03	2003-07-15	Lek Pharmaceutical And Chemical Company D.D.	Controlled release pharmaceutical formulation containing venlafaxine
WO2003082805A1 (en) *	2002-03-28	2003-10-09	Synthon B.V.	Low water-soluble venlafaxine salts
US20030191347A1 (en) *	2002-03-28	2003-10-09	Rolf Keltjens	Venlafaxine base
IL149055A0 (en) *	2002-04-09	2002-11-10	Karma Pharm Ltd	Extended release composition comprising as active compound venlafaxine hydrochloride
BR0312445A (pt) *	2002-06-07	2005-05-10	Ranbaxy Lab Ltd	Sistemas multiunitários para disponibilização de fármaco de liberação modificada
US8216609B2 (en)	2002-08-05	2012-07-10	Torrent Pharmaceuticals Limited	Modified release composition of highly soluble drugs
US7058999B2 (en) *	2002-10-24	2006-06-13	Paramount Bed Co., Ltd.	Electric bed and control apparatus and control method therefor
US6703044B1 (en) *	2002-10-25	2004-03-09	Dexcel Pharma Tech, Ltd	Venlafaxine formulations
EP1558222A2 (de) *	2002-10-25	2005-08-03	Dexcel Pharma Technologies Ltd.	Pharmazeutische zusammensetzungen enthaltend venlafaxine
EP1596837A2 (de) *	2003-02-07	2005-11-23	Omega Farma Ehf	Venlafaxin-formulierungen mit verzogerter freisetzung
ATE336988T1 (de) *	2003-07-30	2006-09-15	Pharmathen Sa	Venlafaxine hydrochloridformulierungen mit verzögerter freisetzung
US7016014B2 (en) *	2004-02-27	2006-03-21	Asml Netherlands B.V	Lithographic apparatus and device manufacturing method

2004
- 2004-10-27 AT AT04821278T patent/ATE361743T1/de not_active IP Right Cessation
- 2004-10-27 JP JP2006552018A patent/JP2007520547A/ja active Pending
- 2004-10-27 EP EP04821278A patent/EP1711169B1/de not_active Expired - Lifetime
- 2004-10-27 HR HR20070353T patent/HRP20070353T3/xx unknown
- 2004-10-27 RU RU2006129034/15A patent/RU2340331C2/ru not_active IP Right Cessation
- 2004-10-27 DK DK04821278T patent/DK1711169T3/da active
- 2004-10-27 ES ES04821278T patent/ES2287813T3/es not_active Expired - Lifetime
- 2004-10-27 WO PCT/IN2004/000340 patent/WO2005074895A1/en not_active Ceased
- 2004-10-27 MX MXPA06008854A patent/MXPA06008854A/es active IP Right Grant
- 2004-10-27 DE DE602004006443T patent/DE602004006443T2/de not_active Expired - Fee Related
- 2004-10-27 BR BRPI0418283-9A patent/BRPI0418283A/pt not_active IP Right Cessation
- 2004-10-27 KR KR1020067014903A patent/KR20070000439A/ko not_active Ceased
- 2004-10-27 NZ NZ548504A patent/NZ548504A/en unknown
- 2004-10-27 PL PL04821278T patent/PL1711169T3/pl unknown
- 2004-10-27 AU AU2004315136A patent/AU2004315136B2/en not_active Ceased
- 2004-10-27 SI SI200430372T patent/SI1711169T1/sl unknown
- 2004-10-27 PT PT04821278T patent/PT1711169E/pt unknown
- 2004-10-27 CA CA2555295A patent/CA2555295C/en not_active Expired - Fee Related
- 2004-10-27 UA UAA200608949A patent/UA82597C2/uk unknown
2005
- 2005-01-07 US US11/031,266 patent/US7807195B2/en not_active Expired - Fee Related
2006
- 2006-08-02 IL IL177243A patent/IL177243A0/en unknown
- 2006-08-25 NO NO20063809A patent/NO20063809L/no not_active Application Discontinuation
2007
- 2007-07-19 CY CY20071100959T patent/CY1106741T1/el unknown

Also Published As

Publication number	Publication date
US20050169985A1 (en)	2005-08-04
UA82597C2 (uk)	2008-04-25
HRP20070353T3 (en)	2008-01-31
AU2004315136B2 (en)	2010-06-17
WO2005074895A1 (en)	2005-08-18
SI1711169T1 (sl)	2007-10-31
IL177243A0 (en)	2006-12-10
MXPA06008854A (es)	2007-01-23
CA2555295A1 (en)	2005-08-18
PT1711169E (pt)	2007-07-23
KR20070000439A (ko)	2007-01-02
AU2004315136A1 (en)	2005-08-18
NO20063809L (no)	2006-08-25
US7807195B2 (en)	2010-10-05
RU2340331C2 (ru)	2008-12-10
BRPI0418283A (pt)	2007-05-02
PL1711169T3 (pl)	2007-10-31
ES2287813T3 (es)	2007-12-16
HK1091137A1 (en)	2007-01-12
RU2006129034A (ru)	2008-03-10
DK1711169T3 (da)	2007-09-17
DE602004006443D1 (de)	2007-06-21
DE602004006443T2 (de)	2008-01-10
CY1106741T1 (el)	2012-05-23
EP1711169A1 (de)	2006-10-18
NZ548504A (en)	2009-03-31
CA2555295C (en)	2011-01-18
JP2007520547A (ja)	2007-07-26
EP1711169B1 (de)	2007-05-09

Legal Events

Date

Code

Title

Description

2007-11-15

UEP

Publication of translation of european patent specification

Ref document number: 1711169

Country of ref document: EP

2010-07-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
CY1106741T1 (el)	2012-05-23	Επικαλυμμενα μινι-δισκια παρατεταμενης αποδεσμευσης υδροχλωρικης βενλαφαξινης
WO2008027557A3 (en)	2008-10-30	Topiramate compositions and methods of enhancing its bioavailability
EA200900264A1 (ru)	2009-08-28	Композиции флибансерина и способ их приготовления
AP2012006231A0 (en)	2012-04-30	Capsule formulation of pirfenidone and pharmaceutically acceptable excipients.
EA200970267A1 (ru)	2009-08-28	ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ВКЛЮЧАЮЩАЯ МНОЖЕСТВО МИНИ-ТАБЛЕТОК, СОДЕРЖАЩИХ ИНГИБИТОР ФАКТОРА Xa
ATE454138T1 (de)	2010-01-15	Tablette mit modifizierter freisetzung von bupropion hydrochlorid
CR8102A (es)	2006-08-09	Derivados de pirazolo- quinazolina, procedimiento para preparacion y su uso como inhibidores de quinasa
EA200801926A1 (ru)	2009-04-28	Таблетки парацетамола с быстрым высвобождением
PH12013502277A1 (en)	2020-10-19	Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4 methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids
JO2973B1 (en)	2016-03-15	Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol
WO2004056337A3 (en)	2004-08-19	Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
BRPI0606883A2 (pt)	2009-12-01	composição farmacêutica para administração oral, método para preparar um tablete, e, forma de dosagem sólida única
BR0314797A (pt)	2005-07-26	Derivados da pirimidineamida e o uso dos mesmos
BRPI0507652A (pt)	2007-07-10	composições farmacêuticas compreendendo um derivado de benzoidiazepina e um inibidor da proeìna de fusão de rsv
NO20081038L (no)	2008-04-23	Farmasoytiske formuleringer/sammensetninger av guanfacin egnet for daglig enkel doseform administrering
TW200616640A (en)	2006-06-01	Novel pharmaceutical formulations of active principles
ATE442158T1 (de)	2009-09-15	Oral verabreichte pharmazeutische zusammensetzungen mit einem abgabemittel in mikronisierter form
MXPA03010054A (es)	2004-04-02	Composiciones que comprenden lopinavir y metodos para aumentar la biodisponibilidad de agentes farmaceuticos.
SG152257A1 (en)	2009-05-29	Topical preparation containing ambroxol
BRPI0513598A (pt)	2008-05-13	formas de dosagem em comprimidos revestidos de liberação entérica
UY30126A1 (es)	2007-09-28	Una nueva sal farmaceuticamente aceptable de 2-hidroxi-3-(5-(morfolin-4-ilmetil)-piridin-2-l)1h-indol-5-carbonitrilo, procedimientos para su preparacion, composiciones que la contienen yaplicaciones
CO6351711A2 (es)	2011-12-20	Combinacion de dosis fija en la forma de una tableta de dos copas o de una sola capa de alisquireno y amlodipina
WO2005107709A3 (en)	2006-12-07	Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
ITMI20050387A1 (it)	2006-09-12	Nuove capsule di gelatina molle
TNSN06242A1 (en)	2007-12-03	Extended release coated minitablets of venlafaxine hydrochloride